Stratagene Shares Continue Rebound as Index Falls | GenomeWeb

Shares of Stratagene gained 9.5 percent to lead all stocks in the BCW Index for the trading week ended Tuesday. The firm's shares have risen 27 percent since hitting a 52-week low on June 27. Stratagene was only one of four companies in the Index to gain ground for the tracking period. Invitrogen and Agilent led the decliners for the week, falling 5.6 percent and 5.3 percent, respectively.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.